Because Listeria monocytogenes is a facultative intracellular pathogen that can survive and replicate within host cells (like macrophages), a robust cell-mediated immune response is essential for its clearance. This involves the activation of T-helper 1 (Th1) cells, which produce interferon-gamma (IFN-γ). IFN-γ is a potent activator of macrophages, enhancing their ability to kill intracellular bacteria. While antibodies (humoral immunity) are effective against extracellular pathogens, they cannot reach bacteria residing within cells.

Secretory IgA is the predominant immunoglobulin found in mucosal secretions, including those of the respiratory and gastrointestinal tracts. Its primary function is to bind to pathogens and prevent them from attaching to and penetrating the mucosal epithelium. This process is called immune exclusion. Without IgA, pathogens can more easily colonize these surfaces, leading to recurrent infections. IgG and IgM are responsible for complement activation and opsonization in the serum, while IgE is involved in antiparasitic responses with eosinophils.

Granuloma formation in response to Mycobacterium tuberculosis is a classic example of a cell-mediated immune response. It involves activated T cells and macrophages. Tumor necrosis factor-alpha (TNF-α), primarily produced by activated macrophages, is essential for both the formation and maintenance of granulomas. It promotes macrophage activation and recruits inflammatory cells. This is clinically relevant because patients treated with TNF-α inhibitors are at increased risk for reactivation of latent tuberculosis. IL-4 promotes Th2 responses, while IL-10 and TGF-β are generally immunosuppressive.

Recurrent infections with encapsulated bacteria of the Neisseria genus (N. meningitidis, N. gonorrhoeae) are a classic presentation of deficiencies in the terminal complement components (C5, C6, C7, C8, C9). These proteins form the membrane attack complex (MAC), which is required for direct lysis of the bacteria. Without a functional MAC, the host is unable to effectively clear these infections. While other immune defects can increase susceptibility to bacterial infections in general, the specific susceptibility to Neisseria strongly points to a terminal complement deficiency.

Leprosy presents on a spectrum. In tuberculoid leprosy, a strong Th1 response (IFN-γ, IL-2) activates macrophages, contains the infection in granulomas, and results in a low bacterial load. In contrast, lepromatous leprosy, as seen in this patient, is characterized by a weak cell-mediated response and a dominant Th2 response. The Th2 cytokines (IL-4, IL-5, IL-10) promote humoral immunity but are ineffective at clearing the intracellular M. leprae. High levels of IL-10 also suppress macrophage activation, allowing for uncontrolled bacterial proliferation.

C-type lectin receptors (CLRs) are a class of pattern recognition receptors that recognize carbohydrate moieties. Dectin-1, a key CLR, specifically recognizes β-glucans, which are major components of fungal cell walls. This recognition is critical for initiating phagocytosis and antifungal inflammatory responses. While some TLRs (e.g., TLR2) can recognize other fungal components like mannans, CLRs are the primary receptors for β-glucans. NLRs recognize intracellular bacterial components, and RLRs recognize intracellular viral RNA.

Relapsing fever Borrelia species, as well as other pathogens like Neisseria gonorrhoeae and influenza virus, evade the adaptive immune system through antigenic variation. The bacteria systematically switch the expression of their major outer surface proteins. The host mounts an effective antibody response against the dominant serotype, clearing it from the blood and causing symptoms to resolve. However, a small subpopulation of bacteria that has switched to a new, antigenically distinct surface protein survives, proliferates, and causes a subsequent relapse of fever. This cycle repeats as the host plays catch-up with the changing antigens.

The primary virulence factor of encapsulated bacteria like S. pneumoniae, H. influenzae type b, and N. meningitidis is their polysaccharide capsule. The capsule is antiphagocytic. It covers underlying components of the bacterial cell wall, such as C3b binding sites, thereby preventing effective opsonization by complement and antibodies. This allows the bacteria to evade clearance by phagocytes like neutrophils and alveolar macrophages. The host eventually overcomes this by producing capsule-specific antibodies (the basis for vaccination), which can act as opsonins.

Legionella pneumophila employs a type IV secretion system to inject effector proteins into the host macrophage cytoplasm. These proteins remodel the phagosome, preventing it from fusing with the acidic, enzyme-filled lysosome. The bacterium then recruits components of the endoplasmic reticulum to the phagosome, creating a unique vacuole where it can replicate safely. Other pathogens that inhibit phagolysosomal fusion include Salmonella (some species) and Mycobacterium tuberculosis. Escaping the phagosome is a strategy used by Listeria and Shigella.

The classical complement pathway is primarily activated by immune complexes. The process begins when the C1 complex, specifically its C1q subunit, binds to the Fc portion of IgG (subtypes 1, 2, and 3) or IgM antibodies that are bound to an antigen. This binding event triggers a conformational change in C1, initiating a proteolytic cascade involving C1r, C1s, C4, and C2, ultimately leading to the formation of the C3 convertase (C4b2a). Mannose-binding lectin initiates the lectin pathway, and the alternative pathway is initiated by spontaneous C3 hydrolysis or stabilized by factors like Factor B.